Mass spectrometry method for measuring vitamin B6 in body fluids

US9234901B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9234901-B2
Application numberUS-201113208295-A
CountryUS
Kind codeB2
Filing dateAug 11, 2011
Priority dateJun 14, 2007
Publication dateJan 12, 2016
Grant dateJan 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are methods of detecting the presence or amount of the active form of vitamin B6, pyridoxal 5′-phosphate, in a body fluid sample using tandem mass spectrometry coupled with liquid chromatography.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for detecting the presence or amount of pyridoxal 5′-phosphate in a body fluid sample by tandem mass spectrometry, comprising: (i) purifying said sample, wherein purifying comprises: (a) applying a body fluid sample and a first solvent to an extraction column under conditions suitable to reversibly retain pyridoxal 5′-phosphate on said extraction column; (b) applying a second solvent to said extraction column under conditions suitable to elute retained pyridoxal 5′-phosphate from the extraction column, wherein said first and second solvents are different; (c) applying eluted pyridoxal 5′-phosphate from the extraction column to an analytical column for chromatographic separation; and (d) applying a third solvent to said analytical column to elute pyridoxal 5′-phosphate from the analytical column; (ii) generating a parent ion of said pyridoxal 5′-phosphate from said purified sample; (iii) generating one or more daughter ions of said parent ion; and (iv) detecting the presence or amount of one or more said ions generated in step (ii) or step (iii) or both, and relating the detected ions to the presence or amount of said pyridoxal 5′-phosphate in said sample. 2. The method of claim 1 , wherein the extraction column is a mixed mode anion exchange polymer column, and the analytical column is a C-8 analytical column. 3. The method of claim 2 , wherein the extraction column comprises particles of about 50 μm, and the analytical column comprises particles of about 3.5 μm. 4. The method of claim 1 , wherein steps (a)-(e) are performed in an online automated fashion. 5. The method of claim 4 , wherein steps (ii)-(iv) are performed in an online automated fashion with steps (a)-(e). 6. The method of claim 1 , wherein said parent ion has a mass/charge ratio of 248.03+/−1. 7. The method of claim 6 , wherein said one or more daughter ions comprise a daughter ion with a mass/charge ratio of 150.00+/−1. 8. The method of claim 1 , wherein said sample comprises plasma. 9. The method of claim 1 , wherein step (ii) is performed by electrospray ionization. 10. The method of claim 1 , wherein step (iii) is performed by Collision-Induced Dissociation using a neutral gas. 11. The method of claim 1 , wherein an internal standard is added to the body fluid sample prior to step (i). 12. The method of claim 11 , wherein the internal standard comprises 2-hydroxy-6-methylpyridine-3-carboxylic acid. 13. The method of claim 12 , wherein the parent ion of the internal standard generated in step (ii) has a mass to charge ratio of 154.04+/−1. 14. The method of claim 12 , wherein the daughter ion of the internal standard generated in step (iii) has a mass to charge ratio of 136.00+/−1. 15. The method of claim 1 , wherein said extraction column is a turbulent flow liquid chromatography column. 16. The method of claim 15 , wherein said turbulent flow liquid chromatography column is a high turbulent flow liquid chromatography column. 17. The method of claim 1 , wherein said analytical column is an high performance liquid chromatography column. 18. The method of claim 17 , wherein steps (ii)-(iv) are performed in an online automated fashion with steps (a)-(e).

Assignees

Inventors

Classifications

  • G01N33/82Primary

    involving vitamins {or their receptors} · CPC title

  • Hetero-N · CPC title

  • Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn · CPC title

  • G01N30/02Primary

    Column chromatography · CPC title

  • Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9234901B2 cover?
Provided are methods of detecting the presence or amount of the active form of vitamin B6, pyridoxal 5′-phosphate, in a body fluid sample using tandem mass spectrometry coupled with liquid chromatography.
Who is the assignee on this patent?
Jiang Qibo, Chan Sum, Reitz Richard, and 1 more
What technology area does this patent fall under?
Primary CPC classification G01N33/82. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).